Controlled release composition using transition coating, and method of preparing same
The present invention is concerned with the use of transition coating and transition coating composition to control and or target the release of active pharmaceutical ingredients, and biological, chemical, neutraceutical, agricultural and nutritional materials and a method of preparing controlled release systems utilizing these components.
1. A controlled delivery composition for controlled release of an active ingredient consisting of:
a tablet comprising the active ingredient;
three coatings substantially surrounding the tablet, wherein the coatings comprise:
a first coat consisting of polyvinyl acetate and, optionally, a plasticizer and/or a channeling agent,
a second coat consisting of ethylcellulose and, optionally a plasticizer and/or a channeling agent, and
a third coat consisting of methacrylate copolymer and, optionally, a plasticizer and/or a channeling agent, wherein the first coat is closest to the tablet and the third coat is the outermost coating; and
two transition zones between the three coatings, wherein a first transition zone is located between the first and the second coating and a second transition zone is located between the second and the third coating, and
wherein, when placed in contact with a liquid milieu, the flow of the active ingredient through the transition zones is at a cross flow relative to the flow of the active ingredient through the three coatings;
wherein the first coat increases by about 2 wt % the weight of the controlled delivery composition compared to the weight of the tablet;
wherein the second coat increases by about 2 wt % the weight of the controlled delivery composition compared to the weight of the tablet and the first coat;
wherein the third coat increases by about 2 wt % the weight of the controlled delivery composition compared to the weight of the tablet, the first coat, and the second coat;
wherein the active ingredient is an antidepressant, an antihypertensive agent, an antianginal agent, an antimanic agent, an antiarrhythmic, a thrombolytic agent, an antifibrinolytic agent, an antiplatelet agent, an anticonvulsant, an antiparkinson agent, a calcium regulation agent, an anticholinergic agent, or a hypolipidemic agent;
wherein the channeling agent is present in one or more of the coatings; and
wherein the channeling agent is a cellulose ether.
2. The controlled delivery composition of claim 1 , wherein the plasticizer is present in one or more of the coatings.
3. The controlled delivery composition of claim 1 , wherein the controlled delivery composition provides a patient with site specific, timed, pulsed, chronotherapeutic, extended, or controlled release of the active ingredient from the tablet.
4. The controlled delivery composition of claim 1 , the tablet further comprising:
at least one material selected from: a filler, a lubricant, an antioxidant, an anti-tacky agent, and a plasticizer agent.
5. The controlled delivery composition of claim 1 , wherein the antidepressant is nefopam, oxypertine, doxepin, amoxapine, trazodone, amitriptyline, maprotiline, phenelzine, desipramine, nortriptyline, tranylcypromine, fluoxetine, doxepin, imipramine, imipramine pamoate, isocarboxazid, trimipramine, venlafaxine, paroxetine, or protriptyline.
6. The controlled delivery composition of claim 1 , wherein the antidepressant is venlafaxine.
7. The controlled delivery composition of claim 1 , wherein the antianginal agent is metoprolol succinate.
8. A controlled delivery composition for controlled release of an active ingredient consisting of:
a tablet comprising the active ingredient;
three coatings substantially surrounding the tablet, wherein the coatings comprise:
a first coat consisting of ethylcellulose and, optionally, a plasticizer and/or a channeling agent,
a second coat consisting of polyvinyl acetate and, optionally a plasticizer and/or a channeling agent, and
a third coat consisting of methacrylate copolymer and, optionally, a plasticizer and/or a channeling agent, wherein the first coat is closest to the tablet and the third coat is the outermost coating; and
two transition zones between the three coatings, wherein a first transition zone is located between the first and the second coating and a second transition zone is located between the second and the third coating, and
wherein, when placed in contact with a liquid milieu, the flow of the active ingredient through the transition zones is at a cross flow relative to the flow of the active ingredient through the three coatings;
wherein the first coat increases by about 2 wt % the weight of the controlled delivery composition compared to the weight of the tablet;
wherein the second coat increases by about 2 wt % the weight of the controlled delivery composition compared to the weight of the tablet and the first coat;
wherein the third coat increases by about 2 wt % the weight of the controlled delivery composition compared to the weight of the tablet, the first coat, and the second coat; wherein the active ingredient is an antidepressant.
9. The controlled release composition of claim 8 , wherein the antidepressant is selected from nefopam, oxypertine, doxepin, amoxapine, trazodone, amitriptyline, maprotiline, phenelzine, desipramine, nortriptyline, tranylcypromine, fluoxetine, doxepin, imipramine, imipramine pamoate, isocarboxazid, trimipramine, venlafaxine, paroxetine, and protriptyline.
10. The controlled release composition of claim 8 , wherein the antidepressant is venlafaxine.